KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Interest Expenses (2017 - 2025)

Guardant Health (GH) has disclosed Interest Expenses for 9 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 82.95% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.9 million through Dec 2025, up 50.99% year-over-year, with the annual reading at $3.9 million for FY2025, 50.99% up from the prior year.
  • Interest Expenses hit $1.2 million in Q4 2025 for Guardant Health, up from $943000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.2 million in Q4 2025 to a low of $643000.0 in Q4 2021.
  • Historically, Interest Expenses has averaged $710500.0 across 5 years, with a median of $645000.0 in 2022.
  • Biggest YoY gain for Interest Expenses was 7950.0% in 2021; the steepest drop was 86.42% in 2021.
  • Year by year, Interest Expenses stood at $643000.0 in 2021, then grew by 0.16% to $644000.0 in 2022, then increased by 0.16% to $645000.0 in 2023, then changed by 0.0% to $645000.0 in 2024, then surged by 82.95% to $1.2 million in 2025.
  • Business Quant data shows Interest Expenses for GH at $1.2 million in Q4 2025, $943000.0 in Q3 2025, and $983000.0 in Q2 2025.